Ascendis Pharma A/S - ADR

NASDAQ:ASND   3:59:50 PM EDT
90.32
-0.18 (-0.20%)
Earnings Announcements

Ascendis Pharma A/S Reports First Quarter 2022 Financial Results

Published: 05/11/2022 20:53 GMT
Ascendis Pharma A/S - ADR (ASND) - Reports First Quarter 2022 Financial Results.
Q1 Loss per Share EUR 2.21.
Q1 Revenue EUR 6.8 Million Versus EUR 700,000.
Q1 Earnings per Share View EUR -2.00, Revenue View EUR 4.7 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $6.85 Million
Adjusted EPS is expected to be -$2.29

Next Quarter Revenue Guidance is expected to be $10.13 Million
Next Quarter EPS Guidance is expected to be -$2.31

More details on our Analysts Page.